This has been confirmed in human trials, where thioguanine has proven to be safe but efficacious for coeliac disease when used at doses below those commonly prescribed.
This has been verified in human clinical tests, where thioguanine has shown to be secure but effective for coeliac disease when administered at doses lower than those typically prescribed.